Return to search results
Bupropion hydrochloride
Bupropion Hydrochloride (XL) is a generic extended-release oral tablet used to treat major depressive disorder and aid smoking cessation. It comes in 150mg and 300mg strengths, marketed under ANDA206556 by sponsors like INVAGEN PHARMS and manufacturers including Exelan Pharmaceuticals and CIPLA USA. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Bupropion Hydrochloride (XL) is a generic extended-release oral tablet used to treat major depressive disorder and aid smoking cessation. It comes in 150mg and 300mg strengths, marketed under ANDA206556 by sponsors like INVAGEN PHARMS and manufacturers including Exelan Pharmaceuticals and CIPLA USA. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Bupropion hydrochloride",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Bupropion hydrochloride — ANDA 211347 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211347"
}
]
|
| identifier | ANDA211347 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-safety",
"fda",
"health-care",
"pharmaceuticals"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Bupropion hydrochloride |
